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epicondylitis occurs as a result of repetitive stress and 
overuse of the wrist and usually affects the dominant 
arm. age, sex, psychosocial factors, leisure- and oc-
cupation-based physical activities are considered to be 
risk factors. common extensor tendon is the anatomical 
structure involved, with the extensor carpi radialis bre-
Introduction
lateral epicondylitis, also known as tennis elbow, is a common complaint in musculoskeletal clinical 
practice. the prevalence of this disease is around 1-3% 
in the population between ages 45 and 55.1 lateral 
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a b s t r a c t
iNtroductioN: lateral epicondylitis is a common painful elbow disorder. several approaches to treatment have been proposed, with a local 
injection of corticosteroids being the most frequently used. recent insights into the pathophysiology encouraged the introduction of autologous 
blood injections as an alternative treatment method. the aim of this meta-analysis is to summarize quantitatively the evidence regarding the ef-
ficacy of corticosteroids and autologous blood injections for treatment of pain in lateral epicondylitis.
EVidENcE acQuisitioN: studies were considered eligible based on the following inclusion criteria: adult human, diagnosis of lateral epi-
condylitis, randomized controlled trials comparing corticosteroids versus autologous blood injections, pain assessment. Exclusion criteria were 
previous surgery for lateral epicondylitis or for other elbow disorders, concurrent treatment with drugs or physiotherapy, diagnosis of muscu-
loskeletal systemic disorder. a systematic search of literature was performed according to the prisMa statement. Effect size of each included 
study was calculated and analyzed in a random-effects model.
EVidENcE syNthEsis: four studies, enrolling total of 218 patients (139 females and 79 males), were included in quantitative analysis. 
at 2 weeks, there was a trend towards a reduction of Vas score in the corticosteroid group (WMd=2.12 [95% ci: 4.38 to 0.14], p=0.07). No 
significant differences were recorded in the medium-term (4-12 weeks; WMD=0.85 [95% CI: -0.44 to 2.15], P=0.19) and long-term (24 weeks; 
WMd=0.63 [95% ci: -2.40 to 3.66], p=0.68) follow-up.
CONCLUSIONS: Few high-quality trials compare the efficacy of corticosteroid and autologous blood injections in the control of pain related 
to lateral epicondylitis. available data indicate that corticosteroids tend to reduce Vas score in short-term follow-up, although these data are not 
statistically significant. No differences were recorded in the medium and long term. Contrary to popular opinion among medical professionals, 
and despite pathophysiological cues, the currently available data offer no support for the effectiveness of autologous blood injections in medium- 
and long-term follow-up. further studies are necessary to establish which treatment has more impact on pain in lateral epicondylitis. these data 
could be then used as a basis for practical guidelines and new protocols of treatment.
(Cite this article as: sirico f, ricca f, di Meglio f, Nurzynska d, castaldo c, spera r, et al. local corticosteroid versus autologous blood injections in 
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Key words: tennis elbow - adrenal cortex hormones - autologous blood transfusion - pain management.
European Journal of physical and rehabilitation Medicine 2017 June;53(3):483-91
doi: 10.23736/s1973-9087.16.04252-0
© 2016 EdiZioNi MiNErVa MEdica
online version at http://www.minervamedica.it
                  COPYRIGHT© 2017 EDIZIONI MINERVA MEDICA 
Th
is
 d
oc
um
en
t i
s 
pr
ot
ec
te
d 
by
 in
te
rn
a
tio
na
l c
op
yr
ig
ht
 la
w
s.
N
o 
ad
di
tio
na
l r
ep
ro
du
ct
io
n 
is 
au
th
or
ize
d.
It 
is
 p
er
m
itt
ed
 fo
r 
pe
rs
on
al
 u
se
 to
 d
ow
n
lo
ad
 a
nd
 s
av
e
 o
n
ly 
on
e 
file
 a
nd
 p
rin
t o
nl
y 
on
e 
co
py
 o
f t
hi
s 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 m
ak
e
 a
dd
itio
na
l c
op
ie
s
(ei
the
r s
po
rad
ica
lly
 o
r s
ys
te
m
at
ica
lly
,
 
e
ith
er
 p
rin
te
d 
or
 e
le
ct
ro
ni
c) 
of 
the
 A
rtic
le
 fo
r 
a
ny
 p
ur
po
se
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 d
ist
rib
u
te
 th
e 
el
ec
tro
ni
c 
co
py
 o
f t
he
 a
rti
cl
e 
th
ro
ug
h 
on
lin
e 
in
te
rn
e
t a
nd
/o
r i
nt
ra
n
e
t f
ile
 s
ha
rin
g 
sy
st
em
s,
 
e
le
ct
ro
ni
c 
m
ai
lin
g 
or
 a
ny
 o
th
er
m
e
a
n
s 
w
hi
ch
 m
ay
 a
llo
w
 a
cc
e
ss
 to
 th
e 
Ar
tic
le
.
Th
e 
us
e 
of
 a
ll 
or
 a
ny
 p
ar
t o
f t
he
 A
rti
cl
e 
fo
r 
a
ny
 C
om
m
er
cia
l U
se
 is
 n
ot
 p
er
m
itt
ed
.T
he
 c
re
at
io
n 
of
 d
er
iva
tiv
e
 w
o
rk
s 
fro
m
 th
e 
Ar
tic
le
 is
 n
ot
 p
er
m
itt
ed
.T
he
 p
ro
du
ct
io
n 
of
 re
pr
in
ts
 fo
r 
pe
rs
on
al
 o
r c
om
m
er
cia
l u
se
 is
n
o
t p
er
m
itt
ed
.I
t i
s 
no
t p
er
m
itt
ed
 to
 re
m
ov
e,
 
co
ve
r,
 
ov
e
rla
y, 
o
bs
cu
re
,
 
bl
oc
k,
 o
r c
ha
ng
e 
an
y 
co
py
rig
ht
 n
ot
ice
s 
or
 te
rm
s 
o
f u
se
 w
hi
ch
 th
e 
Pu
bl
is
he
r m
ay
 p
os
t o
n 
th
e 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 fr
a
m
e
 o
r 
u
se
 fr
a
m
in
g 
te
ch
ni
qu
es
 to
 e
nc
lo
se
 a
ny
 tr
a
de
m
ar
k,
 lo
go
,
o
r 
o
th
er
 p
ro
pr
ie
ta
ry
 in
fo
rm
a
tio
n 
of
 th
e 
Pu
bl
is
he
r.
sirico corticostEroid VS. autoloGous blood iN latEral EpicoNdylitis
484 EuropEaN JourNal of physical aNd rEhabilitatioN MEdiciNE June 2017
conducted combining the following subject heading 
terms: “tennis elbow”, “lateral epicondylitis”, “tendino-
sis”, “tendinitis”, “corticosteroid”, “autologous blood”, 
“injection”. English language restriction was applied. 
Moreover, manual search of published studies was 
also conducted and retrieved study reference list were 
screened. in order to obtain reliable evidence, the analy-
sis has been limited to randomized controlled trials, and 
accordingly has not included observational studies, case 
reports and other studies of lower methodological rigor.
Study selection
The titles and abstracts of the articles identified in 
literature search were screened by three independent 
researchers to assess their eligibility for the analysis. 
full texts of the articles describing randomized con-
trolled trials were obtained. studies were considered 
eligible for qualitative and quantitative analysis based 
on the following inclusion criteria: human (adults >18 
years old), clinical and/or instrumental diagnosis of lat-
eral epicondylitis, randomized controlled trials compar-
ing corticosteroids versus autologous blood injections 
(studies with more complex design were also considered 
and only data regarding corticosteroids and autologous 
blood injection groups were taken into consideration 
for quantitative analysis), pain assessment. Exclusion 
criteria were previous surgery for lateral epicondylitis 
or for other elbow disorders, concurrent treatment with 
drugs or physiotherapy, diagnosis of musculoskeletal 
systemic disorders.
Data extraction and assessment of risk of bias
the following data were extracted from each study: 
sample size, age, sex, number of patients in each treat-
ment arm, follow-up period, and year of publication. 
Measurement of pain treatment outcome by spontane-
ous pain description on Visual analog scale (Vas) was 
recorded. complex evaluation scales combining dif-
ferent items regarding function, strength and pain in a 
single score were not considered, unless it was feasible 
to extract only pain domain assessment value.
the studies included in the analysis were assessed 
for risk of bias using cochrane tools.11 the following 
potential sources of bias were considered: sequence 
generation, allocation concealment, blinding of partici-
vis tendon typically compromised.2 different hypoth-
eses have been proposed over the years to explain the 
etiology of this disorder. histological studies showed 
that inflammation is not the main etiological event in 
the lateral epicondylitis.3 hence, attention was drawn to 
the degeneration of tendon attachment points caused by 
repetitive microtrauma. Indeed, new evidence justifies 
the use of the term “tendinosis”, rather than “tendini-
tis”, as the more appropriate term to describe the tennis 
elbow.
currently, there is no consensus on the best treatment 
of elbow tendinosis. Even though the pathophysiologi-
cal rationale for the use of corticosteroids has not been 
demonstrated, data from previous studies evidenced 
that corticosteroids could be useful in reducing pain in 
short-term follow-up, albeit a worsening of symptoms 
was observed in long term. subsequently, injections of 
autologous blood or blood derivatives, such as plate-
let-rich plasma (prp), abundant in growth factors and 
other mediators of regeneration, have been proposed 
as a treatment.4 injection of prp represents a modern 
approach with a promising application in several mus-
culoskeletal disorders, but its widespread use is limited 
by the specific technical requirements. Therefore, it re-
mains an expensive and non-standardized option.
previous studies 5-9 have attempted to summarize 
the available evidence on the effectiveness of differ-
ent injection therapies, with most authors concluding 
that corticosteroids are advantageous in the short term, 
while autologous blood injection (abi) may have a 
higher efficacy in the long term. However, these con-
clusions are limited to few methodologically different 
studies and need to be analyzed from a systematic point 
of view. therefore, the aim of this meta-analysis is to 
compare the efficacy of these approaches in lateral epi-
condylitis-related pain reduction in the short- and long-
term follow-up.
Evidence acquisition
the study followed a standard systematic review 
protocol, according to the guidelines described in the 
cochrane handbook and recommendations listed in the 
prisMa statement.10 the following databases were 
searched for articles published until april 2015: MEd-
liNE, EMbasE, pubMed, ciNahl, Web of science, 
scopus, and cochrane cENtral. the search was 
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the test used. T2 and T were measured. I2 was used to 
express heterogeneity as percentage. Significant hetero-
geneity was considered if p<0.05 and I2>60%. When 
necessary, meta regression and subgroup analysis were 
performed.
sensitivity analysis was used to assess consistency of 
the results. impact of each study on estimate of sum-
mary effect was investigated using the MEtaNiNf 
command.
Evidence synthesis
Out of 355 articles initially identified, after removal 
of duplicates, titles and abstracts of 126 studies were 
screened. based on inclusion/exclusion criteria speci-
fied above, seven studies comparing corticosteroid 
and autologous blood injections were considered for a 
detailed evaluation and their full texts were retrieved. 
Among them, five 12-16 had a double-arm design and 
allocated patients in ci or abi group, while two 17, 18 
had a more complex design, with three treatment arms 
(comparing ci, abi and extracorporeal shockwave 
therapy 17 or ci, abi and saline injections).18
after detailed evaluation of the full texts, three out of 
seven studies were excluded for the following reasons: 
ozturan et al.17 reported a 0-100 pain assessment scale 
recorded during thomsen test and not the spontaneous 
assessment of pain perception; singh et al.16 used an 
outcome measure reporting a summary score ranging 
from 0 to 100 to assess pain and function of the affected 
arm (patient-rated tennis Elbow Evaluation), hence it 
was impossible to consider only the pain assessment 
score; dojode et al.13 had inconsistency across outcome 
measures. as a result, only four studies were included in 
our quantitative analysis. the outcome of study search 
and selection is reported in figure 1.
the trials included in the analysis enrolled total of 
218 patients (139 females and 79 males) with a mean 
age of 44.8 years (range 38 to 49 years). in the study 
by Wolf et al.,18 9 patients were enrolled in the saline 
injections group; hence, in overall analysis, 104 patients 
were enrolled in ci group and 105 in abi group. all pa-
tients included in our meta-analysis were treated with a 
single injection of corticosteroids or autologous blood. 
arik et al.12 and Jindal et al.14 used 40 mg of methyl-
prednisolone, Wolf et al.18 used 40 mg of triamcinolone 
and Kazemi et al.15 used 20 mg of methylprednisolone 
pants and personnel, blinding of outcome assessment, 
incomplete outcome data, and selective reporting. fol-
lowing cochrane guidelines, each item was judged as 
“low risk”, high risk” or “unclear risk” of bias. due to 
the subjectivity of pain perception, the blinding of par-
ticipants and personnel was considered a factor with the 
highest impact on a study’s risk of bias.
Statistical analysis
the extracted data were analyzed using stata soft-
ware (statacorp. v.12, college station, tX, usa). Ef-
fect sizes and 95% confidence intervals were calculated 
for each study according to data types, using MEtaN 
routine. based on the characteristics of included stud-
ies, summary estimates of effect were calculated with 
a fixed-effects or random-effects model. In random-ef-
fects model, the presence of heterogeneity was assessed 
using Q statistics. p values less than 0.05 (two-tailed) 
were considered significant to reject null hypothesis. P 
values >0.05 were evaluated according to the power of 
figure 1.—the outcome of study search and selection.
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Records identified through database 
searching and other sources: 
Web of science=32
pubmed=52
cochrane central=40
scopus=93
Embase=89
Medline=22
ciNahl=23
other sources=4
(N.=355)
records after duplicates removed
(N.=126)
records screened
(N.=126)
full-text articles assessed
for eligibility
(N.=7)
studies included
in quantitative analysis
(N.=4)
records excluded
(N.=119)
full-text articles excluded,
with reasons (N.=3).
2 study excluded:
outcome measure not
specific for spontaneous
pain assessment
1 study excluded:
inconsistency
of data
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was at low risk of bias, while in the other two studies 
this risk was unclear. attrition bias was detected only in 
Jindal et al.14 No relevant reporting bias or other sources 
of bias were detected. the risks of bias according to the 
cochrane tool are graphically reported in figure 2.
Vas scores were used to estimate summary effect. 
based on the time of follow-up and Vas score evalu-
ation, three different subgroups were defined, namely 
short term (Vas score recorded at 2 weeks), medium 
term (Vas score recorded between 4 and 12 weeks), 
and long term (Vas score recorded at 24 weeks). re-
sults are summarized in figure 3. In short-, medium- and 
long-term follow-up, there were no statistically signifi-
cant differences in Vas scores between ci and abi 
group. Nevertheless, in short term (2 weeks), our analy-
sis showed positive trend in favor of ci, with a mean re-
duction of Vas score 2 points larger than abi (WMd=-
2.12 [95% ci: -4.38 to 0.14]; comparison: p=0.07; 
heterogeneity: χ2=37.07, p<0.05, I2=94.6%, τ2=3.55, 
random-effects model). in medium-term follow-up (4-
12 weeks), the overall effect recorded analyzing all in-
cluded studies did not show significant differences in 
Vas scores between ci and abi (WMd=0.85 [95% ci: 
-0.44 to 2.15]; comparison: p=0.19; heterogeneity: 
χ2=72.53, p<0.05, I2=93.1%, τ2=2.28, random-effects 
model). similarly, the results of sensitivity analysis in 
medium-term follow-up were not statistically signifi-
cant (WMd=0.19 [95 ci: -1.34 to 1.71]; comparison: 
p=0.81, heterogeneity: χ2=44.73, p<0.05, i2=93.3%, 
τ2=2.06, random-effects model). only Wolf et al.18 and 
arik et al.12 studies reported data at 24 weeks and, as 
such, were included in the long-term follow-up sub-
group. as with the previous analysis, the overall ef-
fect was not significant (WMD=0.63 [95% CI: -2.40 
to 3.66]; comparison: P=0.68, heterogeneity: χ2=9.62, 
in ci group. in abi group, the treatment consisted in 
one injection of 2 ml of autologous blood in all the 
studies included in the analysis. both groups received 
1 ml of local anesthetic (lidocaine, lignocaine or prilo-
caine) in addition to autologous blood or corticosteroid 
in the same injection. in all studies, injection was done 
with a single-needle percutaneous access and none re-
ported the use of the peppered injection technique. None 
of the studies reported complications or side effects of 
the treatments, other than short-lived pain after abi.12
the outcome measurements were reported at 2 
weeks,12, 14, 18 4 weeks,12, 15 6 weeks,14 8 weeks,15, 18 
12 weeks,12 and 24 weeks.12, 18 to assess spontaneous 
pain, Vas ranging from 0 (no pain) to 10 (worst pain) 
was adopted in all included studies and was consid-
ered in quantitative analysis. at baseline, Vas score 
was 6.17±1.5 in the ci group and 6.07±1.95 in the abi 
group. As specified earlier, and motivated in the fol-
lowing section, function and strength measurements, 
including Nirschl scale, the disabilities of the arm, 
shoulder and hand (dash) Questionnaire, maximum 
grip strength and pressure pain threshold, were not taken 
into consideration in this meta-analysis, even if reported 
in some of the studies. characteristics of included stud-
ies are summarized in table i.
to begin with, risk of bias of each included study was 
evaluated. only Wolf et al.18 used an adequate method 
to generate randomization sequence and conceal alloca-
tion, and reported the use of aluminum foil on the sy-
ringe during injection in order to blind participants. in 
two studies,14, 15 the methods of randomization and allo-
cation concealment were considered at high risk of bias, 
while in the study of arik et al.,12 the risk of bias was de-
fined as unclear in this regard. In both Jindal et al.14 and 
Kazemi et al.15 studies, blinding of outcome assessment 
Table I.—Summary of studies included in meta-analysis.
study design N.(M/f ratio)
Mean age 
(years) intervention groups
follow-up 
(weeks)
arik et al.8 rct 80 (21/59) 45.2 csi (N.=40): methylprednisolone acetate 40 mg with 2% prilocaine hydrochloride  1 ml
abi (N.=40): venous blood 2 ml with 2% prilocaine hydrochloride 1 ml
2, 4, 12, 24
Jindal et al.10 rct 50 (31/19) 38.1 csi (N.=25): methylprednisolone acetate 40 mg with 2% lignocaine 1 ml
abi (N.=25): venous blood 2 ml with 2% lignocaine 1 ml
2, 6
Kazemi et al.11 rct 60 (11/49) 47.1 csi (N.=30): methylprednisolone 20 mg with 2% lidocaine 1 ml
abi (N.=30): venous blood 2 ml with 2% lidocaine 1 ml
4, 8
Wolf et al.14 rct 28 (16/12) 49.0 csi (9): triamcinolone 40 mg with lidocaine 1 ml
abi (N.=10): venous blood 2 ml with lidocaine 1 ml
si (N.=9): saline 2 ml with lidocaine 1 ml
2, 8, 24
rct: randomized control trial; csi: corticosteroid injection; abi: autologous blood injection; si: saline injection.
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and other symptoms associated with inflammatory pro-
cess. several biological hypotheses have been proposed 
to justify the effect of corticosteroids on pain control, 
such as suppression of prostaglandins, modification of 
connective tissue and extracellular matrix, regulation of 
nociceptive receptors and chemical mediators, modifi-
cation of the relationship between tendon structures and 
paratendinous tissues.19, 20 although none of these hy-
potheses has been definitely confirmed, the effectiveness 
of corticosteroids on pain reduction is clinically demon-
strated. as a matter of fact, existing evidence 21, 22 in-
dicates that ci is more useful than other therapies in 
short term pain reduction. currently, however, no data 
support corticosteroid use on the long term.
Notwithstanding the potential benefits, CI can cause 
moderate side effects, such as skin atrophy, tendon 
rupture, cutaneous rash, pain after injection and, in a 
specific group of patients, serious and systemic effects, 
which could preclude its use. Moreover, based on new 
insights into pathophysiology of tendon disorders, the 
re-evaluation of the role of inflammation is mandatory. 
indeed, a growing body of evidence demonstrates that a 
degenerative process and a failure in healing responses 
of tendon are the key features in many such disorders, 
including lateral epicondylitis.3 for these reasons, new 
approaches to therapy, aimed at modifying degenera-
tive and regenerative mechanisms, have been proposed, 
among them abi. the rationale of this treatment is to 
provide cellular and humoral mediators able to stimu-
late healing cascade.
previous studies have compared ci with other con-
servative treatment options for lateral epicondylitis, 
concluding in favor of the former as regards short-term 
pain reduction.6 in addition, other studies concluded 
that ci is useful in pain reduction within 4 weeks 22 or 
6 weeks.21, 23 When a longer follow-up was taken into 
consideration, Krogh et al.6 observed that there were no 
differences between ci and placebo in terms of pain re-
duction beyond 8 weeks. in the same analysis, results in 
favor of abi were reported (including Kazemi et al.15 
at 8 weeks, creaney et al.24 at 26 weeks, and ozturan et 
al.17 at 52 weeks); however, no data about role of abi 
on the short term were considered.
considering the high prevalence of this disorder in 
the active middle-aged population and the negative 
impact of pain on function, daily activities and qual-
ity of life, the choice of the treatment providing fast 
p≤0.05, I2=89.6%, τ2=4.30, random-effects model). 
due to the small number of studies included in the 
analysis and differences in effect size, a high degree of 
heterogeneity was detected in each group. for the same 
reason, meta regression and evaluation of publication 
bias using the funnel plot were not performed.
While all the studies applied the same abi protocol, 
in ci group, Kazemi et al.15 used 20 mg of steroid, in-
stead of 40 mg as in all other cases, recording the out-
come at 4 and 8 weeks. to reduce heterogeneity, we 
performed the sensitivity analysis with exclusion of Ka-
zemi’s results (figure 4). yet the fact remains that this 
study had the major influence on the summary effect 
estimate in favor of abi in medium-term follow-up, as 
revealed by the assessment of the impact of this study 
using MEtaNiNf command in stata.
Discussion
local ci represents a common approach to the treat-
ment of several musculoskeletal disorders. it is a simple 
and not expensive procedure, aimed at reducing pain 
figure 2.—risk of bias as per the cochrane tool for the studies included 
in this meta-analysis.
arik et al. 2014
Jindal et al. 2013
Kazemi et al. 2010
Wolf et al. 2011
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however, their results should not be generalized because 
of variation in effect between sites of tendinopathy. in 
fact, given the emerging complexity of pathogenesis 
and outcomes of tendinopathies, we could argue that, 
for instance, rotator cuff tendinopathy should be consid-
ered a clinical entity different from lateral epicondylal-
gia. as for the latter diagnosis, only one of the studies 
included in that meta-analysis directly compared the 
effects of corticosteroid injection versus platelet-rich 
plasma. of note, our meta-analysis included four trials 
comparing the effects of corticosteroid versus autolo-
gous blood injection. again, these two treatments (i.e., 
platelet-rich plasma and autologous blood injection) are 
not equivalent and may have different clinical effects. 
in particular, considerable controversy remains about 
the effectiveness of local platelet-rich plasma injection, 
due to differences in preparation, method of platelet 
activation, and experimental design.25 such variability 
was not an issue in our meta-analysis, as all the included 
pain relief should be preferred. incidentally, summary 
effect measured in our analysis indicates that there is 
a positive trend towards ci, with a reduction in Vas 
score 2 points larger than abi at 2 weeks. in the analy-
ses performed in the medium-term subgroup (follow-
up of 4-12 weeks), no significant differences between 
two injection therapies in terms of pain reduction were 
revealed. only two studies 12, 18 reported data at 24 
weeks and were included in the long-term subgroup. 
conclusions from these studies are contradictory, al-
though, in a random-effects model, more weight has 
been assigned to arik et al. (reporting higher efficacy 
of abi in long-term pain relief),12 probably due to a 
lower sample size in the study by Wolf et al.18 Never-
theless, as revealed by the present analysis, summary 
effect remains not significant.
interestingly, coombes et al.5 performed a meta-anal-
ysis of several randomized trials assessing efficacy of 
different types of injections for tendinopathy treatment. 
figure 3.—Vas score in the short, medium, and long term.
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scores were used to estimate summary effect. similarly, 
ozturan et al.17 was excluded, as they used thomsen 
provocative testing, upper extremity functional scores 
and maximal grip strength for outcome evaluation. as 
for their pain evaluation, spontaneous pain score, as in 
Vas, could not be extrapolated from the provocative 
testing for purpose of our meta-analysis. second, the 
work by dojode et al.13 was excluded due to inconsis-
tencies in reporting the Vas score. third, in the study 
conducted by singh et al.16 the primary outcome was 
patient-rated tennis Elbow Evaluation (prtEE), which 
consists of 15 items. in that study, the authors them-
selves underline the differences between the prtEE 
and Vas scoring systems; the same differences are the 
reason why their work could not be included in the pres-
ent meta-analysis.
since Vas is a meaningful and widely accepted scale 
to assess pain, raw mean difference was adequate to 
calculate effect size. this statistical approach represents 
studies used venous blood injection in a homogenous 
groups of patients and comparable protocols.
a recent study by Qian et al.7 compared abps with 
csi, where abps meant both abi and prp injections. 
Arguably, such grouping could influence the results, as 
these treatments can have different mechanisms of ac-
tion, thus different effects on pain in lateral epicondy-
litis. of note, the study by Qian et al. has allowed dif-
ferent methods of the evaluation of treatment effects to 
be considered, including the Vas and the patient-rated 
forearm Evaluation Questionnaire or other pain scores. 
as for pain evaluation, it is possible that the method of 
measurement profoundly influences the results and dif-
ferent methods of measurement do not give correspond-
ing results. hence, it is not advisable to extrapolate data 
from results obtained through different measures. to 
overcome this problem and guarantee the validity of pain 
measurement, only the studies using and reporting the 
Vas score were included in our meta-analysis and Vas 
figure 4.—sensitivity analysis.
                  COPYRIGHT© 2017 EDIZIONI MINERVA MEDICA 
Th
is
 d
oc
um
en
t i
s 
pr
ot
ec
te
d 
by
 in
te
rn
a
tio
na
l c
op
yr
ig
ht
 la
w
s.
N
o 
ad
di
tio
na
l r
ep
ro
du
ct
io
n 
is 
au
th
or
ize
d.
It 
is
 p
er
m
itt
ed
 fo
r 
pe
rs
on
al
 u
se
 to
 d
ow
n
lo
ad
 a
nd
 s
av
e
 o
n
ly 
on
e 
file
 a
nd
 p
rin
t o
nl
y 
on
e 
co
py
 o
f t
hi
s 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 m
ak
e
 a
dd
itio
na
l c
op
ie
s
(ei
the
r s
po
rad
ica
lly
 o
r s
ys
te
m
at
ica
lly
,
 
e
ith
er
 p
rin
te
d 
or
 e
le
ct
ro
ni
c) 
of 
the
 A
rtic
le
 fo
r 
a
ny
 p
ur
po
se
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 d
ist
rib
u
te
 th
e 
el
ec
tro
ni
c 
co
py
 o
f t
he
 a
rti
cl
e 
th
ro
ug
h 
on
lin
e 
in
te
rn
e
t a
nd
/o
r i
nt
ra
n
e
t f
ile
 s
ha
rin
g 
sy
st
em
s,
 
e
le
ct
ro
ni
c 
m
ai
lin
g 
or
 a
ny
 o
th
er
m
e
a
n
s 
w
hi
ch
 m
ay
 a
llo
w
 a
cc
e
ss
 to
 th
e 
Ar
tic
le
.
Th
e 
us
e 
of
 a
ll 
or
 a
ny
 p
ar
t o
f t
he
 A
rti
cl
e 
fo
r 
a
ny
 C
om
m
er
cia
l U
se
 is
 n
ot
 p
er
m
itt
ed
.T
he
 c
re
at
io
n 
of
 d
er
iva
tiv
e
 w
o
rk
s 
fro
m
 th
e 
Ar
tic
le
 is
 n
ot
 p
er
m
itt
ed
.T
he
 p
ro
du
ct
io
n 
of
 re
pr
in
ts
 fo
r 
pe
rs
on
al
 o
r c
om
m
er
cia
l u
se
 is
n
o
t p
er
m
itt
ed
.I
t i
s 
no
t p
er
m
itt
ed
 to
 re
m
ov
e,
 
co
ve
r,
 
ov
e
rla
y, 
o
bs
cu
re
,
 
bl
oc
k,
 o
r c
ha
ng
e 
an
y 
co
py
rig
ht
 n
ot
ice
s 
or
 te
rm
s 
o
f u
se
 w
hi
ch
 th
e 
Pu
bl
is
he
r m
ay
 p
os
t o
n 
th
e 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 fr
a
m
e
 o
r 
u
se
 fr
a
m
in
g 
te
ch
ni
qu
es
 to
 e
nc
lo
se
 a
ny
 tr
a
de
m
ar
k,
 lo
go
,
o
r 
o
th
er
 p
ro
pr
ie
ta
ry
 in
fo
rm
a
tio
n 
of
 th
e 
Pu
bl
is
he
r.
sirico corticostEroid VS. autoloGous blood iN latEral EpicoNdylitis
490 EuropEaN JourNal of physical aNd rEhabilitatioN MEdiciNE June 2017
more stringent inclusion criteria for trial selection 
have been applied and those limitations have been 
completely resolved.
Limitations of the study
a major limitation of the present meta-analysis re-
mains the small number of included studies; however, 
this is due to the scarcity of high quality studies that 
compare effects of ci and abi. another limitation con-
sists in the fact that the studies are often at high or un-
clear risk of bias, assessed using cochrane tool. for these 
reasons, further well-designed studies are mandatory to 
compare these two treatment options. Notwithstanding 
these limitations, the available data, cumulatively and 
quantitatively evaluated in this meta-analysis, point to 
the positive effects of ci in the short-term and abi in 
the long-term pain relief. These findings seem to be jus-
tified also from the etiological point of view, since the 
corticosteroids could provide an immediate control of 
inflammatory response able to modify pain perception, 
while the autologous blood could stimulate tendon heal-
ing process able to obtain stable results in the long term. 
However, current data are not sufficient to confirm this 
hypothesis statistically.
based on the above discussion, the present meta-
analysis could have important implications on re-
search and current clinical practice. unquestionably, 
the results underline the lack of studies comparing ci 
and ABI, as the available evidence is not sufficient to 
conclude in favor of one or the other. although some 
studies have encouraged the use of abi in the long-
term control of pain, statistics do not support this rec-
ommendation. in this connection, it is important to 
emphasize that clinical trials mostly applied only a 
single injection protocol and a short follow-up period. 
hence, to assess the promising long term effects of 
abi on pain control, studies with an adequate follow-
up are mandatory. Moreover, studies with complex 
treatment protocol including multiple injections of ci 
and abi may be necessary in order to develop new 
treatment strategy that could guarantee the best pain 
control and clinical management of lateral epicondyli-
tis. a better knowledge of possible treatment outcomes 
should determine a more conscious application of dif-
ferent therapeutic injections in course of the disorder. 
If future findings are able to confirm the short-term 
an advantage in reporting results, allowing to avoid log 
data transformation and interpret results immediately. 
considering characteristics of the included studies and 
reported differences in study population, design and 
outcome measures, a fixed-effect model was not appro-
priate to define a summary effect.26 for this reason, a 
random-effects model was used in our analysis.
arirachakaran et al.8 have recently performed a 
network meta-analysis, i.e. multiple treatment com-
parison meta-analysis of randomized controlled trials, 
comparing clinical outcomes between the prp, abi, 
and csi. that methodology combines direct evidence 
obtained within randomized clinical trials and indi-
rect evidence obtained across trials through a common 
comparator. Notwithstanding its attractiveness, such 
approach has not yet been validated and implemented 
in clinical decision making, and it should be based on 
high number of carefully selected and assessed clini-
cal randomized trials. in this respect, it is worth noting 
that, among ten studies included in the network meta-
analysis by arirachakaran et al., only three have com-
pared directly abi and csi. importantly, we argue that 
the results of prp injections should not be included 
in a meta-analysis (and even more importantly, in a 
network meta-analysis) until the procedure becomes 
standardized from the methodological and technical 
point of view, as both the preparation and intratendi-
nous injection technique of prp appear to be of great 
clinical significance.25
interestingly, dong et al.9 have attempted an evalu-
ation of the effects of different treatments in lateral 
epicondylitis at 6 months. based on their network 
meta-analysis, the authors conclude that hyaluro-
nate injection and prolotherapy are the most effective 
treatments. other commonly used injection therapies, 
including prp and abi can be considered as treat-
ment candidates, while corticosteroid injection is not 
recommended. the recommendations of the authors 
regarding the use of hyaluronate, however, are based 
on a single study and should be supported by more 
clinical data. Moreover, other important limitations 
of that analysis should be noted, as the differences in 
pain scoring systems, treatment schedules and dos-
ages, and follow-up period have been ignored. Even 
though the conclusions reached by dong et al. and 
our conclusions partially overlap (abi may be a bet-
ter choice than ci in the long term), in our analysis 
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bayesian network meta-analysis. br J sports Med 2016;50:900- 
8.
10. Moher d, liberati a, tetzlaff J, altman dG; prisMa Group. pre-
ferred reporting items for systematic reviews and meta-analyses: the 
prisMa statement. J clin Epidemiol 2009;62:1006-12.
11. higgins Jpt, altman dG, sterne Jac. assessing risk of bias in in-
cluded studies. in: higgins Jpt, Green s, editors. cochrane hand-
book for systematic reviews of interventions Version 5.1.0 (updated 
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12. arik ho, Kose o, Guler f, deniz G, Egerci of, ucar M. injection 
of autologous blood versus corticosteroid for lateral epicondylitis: 
a randomised controlled study. J orthop surg (hong Kong) 2014; 
22:333-7.
13. Dojode CM. A randomised control trial to evaluate the efficacy of 
autologous blood injection versus local corticosteroid injection for 
treatment of lateral epicondylitis. bone Joint res 2012;1:192-7.
14. Jindal N, Gaury y, banshiwal rc, lamoria r, bachhal V. compari-
son of short term results of single injection of autologous blood and 
steroid injection in tennis elbow: a prospective study. J orthop surg 
res 2013;8:10.
15. Kazemi M, azma K, tavana b, rezaiee Moghaddam f, panahi a. 
autologous blood versus corticosteroid local injection in the short-
term treatment of lateral elbow tendinopathy: a randomized clinical 
trial of efficacy. Am J Phys Med Rehabil 2010;89:660-7.
16. singh a, Gangwar ds, shekhar. autologous blood versus corticos-
teroid local injection for treatment of lateral Epicondylosis: a ran-
domized clinical trial. online Journal of health and allied sciences 
2013;12:1-3.
17. ozturan KE, yucel i, cakici h, Guven M, sungur i. autologous blood 
and corticosteroid injection and extracoporeal shock wave therapy in 
the treatment of lateral epicondylitis. orthopedics 2010;33:84-91.
18. Wolf JM, ozer K, scott f, Gordon MJ, Williams aE. comparison of 
autologous blood, corticosteroid, and saline injection in the treatment 
of lateral epicondylitis: a prospective, randomized, controlled multi-
center study. J hand surg am 2011;36:1269-72.
19. paavola M, Kannus p, Järvinen ta, Järvinen tl, Józsa l, Järvinen 
M. treatment of tendon disorders. is there a role for corticosteroid 
injection? foot ankle clin 2002;7:501-13.
20. Gaujoux-Viala C, Dougados M, Gossec L. Efficacy and safety of 
steroid injections for shoulder and elbow tendonitis: a meta-analy-
sis of randomised controlled trials. ann rheum dis 2009;68:1843-
9.
21. smidt N, van der Windt da, assendelft WJ, devillé Wl, Korthals-
de bos ib, bouter lM. corticosteroid injections, physiotherapy, or a 
wait-and-see policy for lateral epicondylitis: a randomised controlled 
trial. lancet 2002;359:657-62.
22. hay EM, paterson sM, lewis M, hosie G, croft p. pragmatic ran-
domised controlled trial of local corticosteroid injection and nap-
roxen for treatment of lateral epicondylitis of elbow in primary care. 
bMJ 1999;319:964-8.
23. bisset l, beller E, Jull G, brooks p, darnell r, Vicenzino b. Mobili-
sation with movement and exercise, corticosteroid injection, or wait 
and see for tennis elbow: randomised trial. bMJ 2006;333:939.
24. creaney l, Wallace a, curtis M, connel d. Growth factor-based 
therapies provide additional benefit beyond physical therapy in re-
sistant elbow tendinopathy: a prospective, single-blind, randomised 
trial of autologous blood injections versus platelet-rich plasma injec-
tions. br J sports Med 2011;45:966-71.
25. fitzpatrick J, bulsara M, Zheng Mh. the Effectiveness of platelet-
rich plasma in the treatment of tendinopathy: a Meta-analysis of 
randomized controlled clinical trials. am J sports Med 2016 Jun 6. 
[Epub ahead of print]
effectiveness of ci and the hypothesized advantage of 
abi in long-term follow-up, a multiple injection pro-
tocol of treatment could be proposed.
Conclusions
in conclusion, the present meta-analysis compared ci 
and abi treatment for pain control in lateral epicondy-
litis. only few published studies met the inclusion cri-
teria. in the included studies, a high risk of bias in some 
aspects and a high degree of heterogeneity in results 
have been reported. Even though the present data are not 
statistically significant, CI tends to reduce VAS score 
more than abi in short-term follow-up. No differences 
have been recorded between two treatment options in 
medium and long term and, importantly, no evidence 
is available to support the use of abi in long-term pain 
management. therefore, further well-designed studies 
are necessary to establish the effectiveness of ci and 
abi in the management of pain in lateral epicondylitis.
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